Clinical Drug Experience Knowledgebase

aripiprazole (abilify) (1 trial)

bupropion (wellbutrin) (1 trial)

calcium carbonate (1 trial)

clarithromycin (biaxin) (1 trial)

escitalopram (lexapro) (2 trials)

esomeprazole (nexium) (1 trial)

lamotrigine (lamictal) (1 trial)

lithium (lithonate) (1 trial)

metronidazole (flagyl) (1 trial)

mirtazapine (remeron) (1 trial)

paliperidone (invega) (1 trial)

paroxetine (paxil) (1 trial)

peritoneal dialysis fluid (1 trial)

polydeoxyribonucleotide (1 trial)

risperidone (risperdal) (1 trial)

venlafaxine (effexor) (1 trial)

vitamin d3 (1 trial)

alteplase (Activase) (1 trial)

capecitabine (xeloda) (1 trial)

cisplatin (platinol) (2 trials)

clonidine (catapres) (1 trial)

esmolol (brevibloc) (1 trial)

ethambutol (myambutol) (2 trials)

fluorouracil (efudex) (2 trials)

gimeracil (1 trial)

hyaluronidase (human recombinant) (hylenex) (1 trial)

hydralazine (apresoline) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

isoniazid (nydrazid) (3 trials)

labetalol (trandate) (1 trial)

losartan (cozaar) (2 trials)

metoprolol (lopressor) (1 trial)

mg1109 (2 trials)

nicardipine (cardene) (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

oteracil (1 trial)

oxaliplatin (eloxatin) (1 trial)

phentolamine mesylate (regitine) (1 trial)

progesterone (progestasert) (1 trial)

pyrazinamide (Aldinamide) (3 trials)

rifampin (2 trials)

s-1 (1 trial)

tegafur (1 trial)

triamcinolone (kenalog) (1 trial)

uropidil (1 trial)

actinidia arguta (1 trial)

allogeneic bone marrow derived mesenchymal stem cell (1 trial)

aluminum hydroxide (Gaviscon) (1 trial)

atropine (2 trials)

autologous peripheral blood mononuclear cells (1 trial)

autologous umbilical cord blood (2 trials)

axitinib (inlyta) (1 trial)

carboplatin (paraplatin) (3 trials)

citric acid (1 trial)

clonazepam (klonopin) (1 trial)

crizotinib (xalkori) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

cytarabine (cytosar-u) (1 trial)

dasatinib (sprycel) (1 trial)

dexmedetomidine (precedex) (1 trial)

erlotinib (tarceva) (1 trial)

etoposide (vepesid) (3 trials)

everolimus (zortress) (1 trial)

fludarabine (fludara) (2 trials)

ifosfamide (ifex) (2 trials)

imatinib (gleevec) (1 trial)

iobenguane sulfate i-131 (1 trial)

levofloxacin (levaquin) (1 trial)

lidocaine (xylocaine) (1 trial)

linezolid (zyvox) (2 trials)

magnesium oxide (1 trial)

melphalan (alkeran) (2 trials)

neostigmine (bloxiverz) (2 trials)

opc-67683 (1 trial)

pazopanib (votrient) (2 trials)

polyethylene glycol (1 trial)

rpa102 (1 trial)

ruxolitinib (jakafi) (1 trial)

sargramostim (leukine) (2 trials)

sodium chloride (1 trial)

sodium phosphate (1 trial)

sodium picosulfate (1 trial)

sorafenib (nexavar) (1 trial)

sugammadex (bridion) (2 trials)

thiotepa (1 trial)

trastuzumab (herceptin) (1 trial)

vandetanib (caprelsa) (1 trial)

vemurafenib (zelboraf) (1 trial)

vitamin c (1 trial)

ckd-386 (1 trial)

d013 (1 trial)

d326 (1 trial)

d337 (1 trial)

kanamycin (kantrex) (1 trial)

midazolam (versed) (1 trial)

moxifloxacin (avelox) (1 trial)

mycophenolate (myfortic) (3 trials)

tacrolimus (prograf) (2 trials)

astaxanthin (1 trial)

autologous islet (1 trial)

celecoxib (celebrex) (1 trial)

epoetin (Epogen) (1 trial)

fentanyl (Innovar) (1 trial)

flecainide (tambocor) (1 trial)

glyburide (micronase) (1 trial)

mulberry leaf extract (1 trial)

oral mucosal epithelial cell (1 trial)

plantago asiatica l. extract (1 trial)

sitagliptin (januvia) (1 trial)

vildagliptin (1 trial)